OMERS backing hepatitis C drug, BCI acquiring stake in space technology company
The pharmaceutical arm of the Ontario Municipal Employees’ Retirement System is acquiring a stake in an anti-viral drug. According to the terms of a $200-million deal between OMERS Life Sciences and Enanta Pharmaceuticals Inc., the pension fund will receive a 54.5 per cent stake on the first US$284 million in royalties earned by the hepatitis […]
- May 4, 2023 May 4, 2023
- 12:30